Marc L Peters-Golden MD
Critical Care Medicine, Pleural Disease
Professor, Internal Medicine, University of Michigan Medical School
Join to View Full Profile
1500 East Medical Center Dr3rd Floor Taubman Ctr Recp CAnn Arbor, MI 48109
Phone+1 734-647-9342
Fax+1 734-615-5348
Dr. Peters-Golden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1981 - 1984
Tufts Medical CenterResidency, Internal Medicine, 1978 - 1981
Duke University School of MedicineClass of 1978
Certifications & Licensure
MI State Medical License 1984 - 2024
MD State Medical License 1981 - 1985
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 1996
Publications & Presentations
PubMed
- Distinct cAMP regulation in scleroderma lung and skin myofibroblasts governs their dedifferentiation via p38α inhibition.Jared D Baas, John Varga, Carol Feghali-Bostwick, Marc Peters-Golden, Sean M Fortier
Biorxiv. 2025-03-01 - 5 citationsMAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.Sean M Fortier, Natalie M Walker, Loka R Penke, Jared D Baas, Qinxue Shen
The Journal of Clinical Investigation. 2024-03-21 - 3 citationsGTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress.Weihua Zhou, Zitong Zhao, Angelica Lin, John Z Yang, Jie Xu
Cancer Discovery. 2024-01-12
Press Mentions
Sixteen Individuals, and Members of Comprehensive Stroke Program, Honored with Faculty and Staff AwardsDecember 13th, 2024
Grant Support
- Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and FibrosisUNIVERSITY OF MICHIGAN AT ANN ARBOR2019–2026
- Prostanoids, Plasminogen Actication, And Personalized Therapeutics In IPFNational Heart, Lung, And Blood Institute2011
- Control Of Fibroblast Function By Prostaglandin E2 And Plasminogen ActivationNational Heart, Lung, And Blood Institute2009–2011
- Eicosanoids And Lung Macrophage Antimicrobial MechanismsNational Heart, Lung, And Blood Institute2000–2011
- Eicosanoids And Lung Macrophage Antimicrobial MechanismsNational Heart, Lung, And Blood Institute2008
- Eisosanoid Imbalance In Fibrotic Lung DiseaseNational Heart, Lung, And Blood Institute2002–2005
- Deficient Cyclooxygenase Expression In IPF FibroblastsNational Heart, Lung, And Blood Institute1997–2001
- Leukotrienes And Pulmonary Antibacterial DefenseNational Heart, Lung, And Blood Institute1997–1999
- Molecular Regulation Of Macrophage 5-LipoxygenaseNational Heart, Lung, And Blood Institute1992–1995
- Determinants Of Lung Macrophage Arachidonate MetabolismNational Heart, Lung, And Blood Institute1986–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
